Wave Life Sciences (WVE) Operating Leases: 2019-2025
Historic Operating Leases for Wave Life Sciences (WVE) over the last 7 years, with Sep 2025 value amounting to $11.4 million.
- Wave Life Sciences' Operating Leases fell 42.45% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 42.45%. This contributed to the annual value of $17.8 million for FY2024, which is 30.07% down from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Operating Leases is $11.4 million, which was down 16.18% from $13.6 million recorded in Q2 2025.
- In the past 5 years, Wave Life Sciences' Operating Leases ranged from a high of $35.2 million in Q2 2022 and a low of $11.4 million during Q3 2025.
- Its 3-year average for Operating Leases is $21.4 million, with a median of $21.7 million in 2024.
- Its Operating Leases has fluctuated over the past 5 years, first soared by 49.78% in 2022, then slumped by 42.45% in 2025.
- Quarterly analysis of 5 years shows Wave Life Sciences' Operating Leases stood at $25.0 million in 2021, then rose by 28.70% to $32.1 million in 2022, then declined by 20.90% to $25.4 million in 2023, then slumped by 30.07% to $17.8 million in 2024, then slumped by 42.45% to $11.4 million in 2025.
- Its Operating Leases stands at $11.4 million for Q3 2025, versus $13.6 million for Q2 2025 and $15.7 million for Q1 2025.